Results of meta-analysis for polymorphisms and treatment response of nAMD
FEM or REM* | Heterogeneity | ||||||||
---|---|---|---|---|---|---|---|---|---|
Gene | Polymorphism | No. of cohorts | Genetic model | OR (95% CI) | p | P (Q) | I2 (%) | Egger's test (p) | |
VEGF-A | Rs699947 A>C | Overall | A vs C | 1.030 (0.915 to 1.161) | 0.622 | 0.370 | 7.8 | 0.282 | |
AA vs CC | 1.078 (0.842 to 1.378) | 0.553 | 0.133 | 35.6 | 0.349 | ||||
AC vs CC | 1.089 (0.894 to 1.326) | 0.156 | 0.559 | 0.0 | 0.161 | ||||
AA vs AC+CC | 1.165 (0.787 to 1.726) | 0.445 | 0.010 | 60.4 | 0.161 | ||||
AA+AC vs CC | 1.083 (0.898 to 1.306) | 0.403 | 0.887 | 0.0 | 0.281 | ||||
Sub-analysis by ethnicity | Caucasian | A vs C | 1.008 (0.888 to 1.143) | 0.906 | 0.372 | 7.5 | n.a | ||
AA vs CC | 0.983 (0.759 to 1.273) | 0.897 | 0.407 | 3.0 | n.a | ||||
AC vs CC | 1.168 (0.942 to 1.448) | 0.156 | 0.768 | 0.0 | n.a | ||||
AA vs AC+CC | 0.983 (0.707 to 1.368) | 0.930 | 0.105 | 41.0 | n.a | ||||
AA+AC vs CC | 1.110 (0.905 to 1.360) | 0.316 | 0.857 | 0.0 | n.a | ||||
East Asia | A vs C | 1.238 (0.862 to 1.777) | 0.247 | n.a | n.a | n.a | |||
AA vs CC | 3.000 (1.190 to 7.566) | 0.020 | n.a | n.a | n.a | ||||
AC vs CC | 0.735 (0.443 to 1.221) | 0.235 | n.a | n.a | n.a | ||||
AA vs AC+CC | 3.482 (1.427 to 8.496) | 0.006 | n.a | n.a | n.a | ||||
AA+AC vs CC | 0.947 (0.586 to 1.528) | 0.822 | n.a | n.a | n.a | ||||
Rs 699946 A>G | Overall | A vs G | 1.016 (0.863 to 1.198) | 0.846 | 0.332 | 9.3 | n.a | ||
AA vs GG | 1.031 (0.665 to 1.600) | 0.890 | 0.253 | 27.3 | 0.841 | ||||
AG vs GG | 1.066 (0.687 to 1.654) | 0.776 | 0.407 | 0.0 | 0.408 | ||||
AA vs AG+GG | 1.013 (0.828 to 1.239) | 0.900 | 0.497 | 0.0 | 0.657 | ||||
AA+AG vs GG | 1.051 (0.692 to 1.597) | 0.815 | 0.294 | 18.2 | 0.685 | ||||
Sub-analysis by ethnicity | Caucasian | A vs G | 1.039 (0.862 to 1.254) | 0.686 | 0.159 | 49.5 | n.a | ||
AA vs GG | 1.114 (0.629 to 1.927) | 0.712 | 0.103 | 62.5 | n.a | ||||
AG vs GG | 1.081 (0.600 to 1.947) | 0.795 | 0.179 | 44.5 | n.a | ||||
AA vs AG+GG | 1.039 (0.834 to 1.295) | 0.733 | 0.298 | 7.6 | n.a | ||||
AA+AG vs GG | 1.103 (0.625 to 1.944) | 0.735 | 0.119 | 58.9 | n.a | ||||
East Asia | A vs G | 0.944 (0.672 to 1.327) | 0.739 | n.a | n.a | n.a | |||
AA vs GG | 0.918 (0.458 to 1.841) | 0.810 | n.a | n.a | n.a | ||||
AG vs GG | 1.047 (0.540 to 2.028) | 0.892 | n.a | n.a | n.a | ||||
AA vs AG+GG | 0.888 (0.539 to 1.464) | 0.642 | n.a | n.a | n.a | ||||
AA+AG vs GG | 0.991 (0.531 to 1.848) | 0.978 | n.a | n.a | n.a | ||||
Rs 833069 C>T | Caucasian | C vs T | 0.961 (0.827 to 1.115) | 0.598 | 0.650 | 0.0 | 0.514 | ||
CC vs TT | 0.824 (0.591 to 1.148) | 0.253 | 0.790 | 0.0 | 0.306 | ||||
CT vs TT | 1.088 (0.880 to 1.347) | 0.435 | 0.313 | 14.0 | 0.306 | ||||
CC vs CT+TT | 0.795 (0.582 to 1.085) | 0.149 | 0.728 | 0.0 | 0.496 | ||||
CC+CT vs TT | 1.026 (0.839 to 1.255) | 0.803 | 0.412 | 0.0 | 0.996 | ||||
Rs 833061 C>T | Overall | C vs T | 1.266 (0.983 to 1.631) | 0.067 | 0.406 | 0.0 | 0.882 | ||
CC vs TT | 2.222 (1.252 to 3.944) | 0.006 | 0.292 | 19.6 | 0.326 | ||||
CT vs TT | 2.537 (1.478 to 4.356) | 0.001 | 0.227 | 30.9 | 0.882 | ||||
CC vs CT+TT | 2.362 (1.414 to 3.946) | 0.001 | 0.214 | 33.1 | 0.145 | ||||
CC+CT vs TT | 1.029 (0.718 to 1.476) | 0.876 | 0.758 | 0.0 | 0.765 | ||||
Sub-analysis by ethnicity | Caucasian | C vs T | 1.302 (0.912 to 1.859) | 0.146 | 0.239 | 30.1 | n.a | ||
CC vs TT | 1.845 (0.882 to 3.861) | 0.104 | 0.200 | 37.9 | n.a | ||||
CT vs TT | 1.989 (1.011 to 3.910) | 0.046 | 0.204 | 37.0 | n.a | ||||
CC vs CT+TT | 1.937 (1.025 to 3.661) | 0.042 | 0.163 | 44.9 | n.a | ||||
CC+CT vs TT | 1.136 (0.655 to 1.969) | 0.649 | 0.618 | 0.0 | n.a | ||||
East Asia | C vs T | 1.231 (0.859 to 1.763) | 0.258 | n.a | n.a | n.a | |||
CC vs TT | 2.903 (1.150 to 7.330) | 0.024 | n.a | n.a | n.a | ||||
CT vs TT | 3.849 (1.522 to 9.733) | 0.004 | n.a | n.a | n.a | ||||
CC vs CT+TT | 3.339 (1.369 to 8.145) | 0.008 | n.a | n.a | n.a | ||||
CC+CT vs TT | 0.955 (0.592 to 1.541) | 0.850 | n.a | n.a | n.a | ||||
Rs 2146323 A>C | Caucasian | A vs C | 1.000 (0.859 to 1.164) | 1.000 | 0.701 | 0.0 | 0.534 | ||
AA vs CC | 0.909 (0.644 to 1.282) | 0.585 | 0.526 | 0.0 | 0.465 | ||||
AC vs CC | 1.103 (0.888 to 1.369) | 0.375 | 0.903 | 0.0 | 0.356 | ||||
AA vs AC+CC | 0.867 (0.627 to 1.199) | 0.389 | 0.434 | 0.0 | 0.500 | ||||
AA+AC vs CC | 1.061 (0.863 to 1.304) | 0.574 | 0.902 | 0.0 | 0.277 | ||||
Rs 1413711 T>C | Caucasian | T vs C | 0.961 (0.832 to 1.109) | 0.583 | 0.635 | 0.0 | n.a | ||
TT vs CC | 0.912 (0.683 to 1.216) | 0.530 | 0.600 | 0.0 | 0.456 | ||||
TC vs CC | 1.199 (0.940 to 1.531) | 0.144 | 0.688 | 0.0 | 0.456 | ||||
TT vs TC+CC | 0.811 (0.638 to 1.032) | 0.089 | 0.256 | 26.7 | 0.972 | ||||
TT+TC vs CC | 1.096 (0.871 to 1.379) | 0.434 | 0.896 | 0.0 | 0.613 | ||||
Rs 2010963 C>G | Caucasian | C vs G | 0.994 (0.852 to 1.161) | 0.943 | 0.892 | 0.0 | 0.229 | ||
CC vs GG | 0.722 (0.340 to 1.535) | 0.398 | 0.040 | 68.9 | 0.242 | ||||
CG vs GG | 0.874 (0.520 to 1.470) | 0.612 | 0.025 | 72.9 | 0.871 | ||||
CC vs CG+GG | 0.831 (0.604 to 1.144) | 0.257 | 0.773 | 0.0 | 0.749 | ||||
CC+CG vs GG | 1.075 (0.871 to 1.327) | 0.501 | 0.668 | 0.0 | 0.416 | ||||
Rs1570360 A>G | Caucasian | A vs G | 1.378 (0.318 to 5.973) | 0.668 | 0.007 | 86.1 | n.a | ||
AA vs GG | 1.895 (0.046 to 77.497) | 0.736 | 0.018 | 82.0 | n.a | ||||
AG vs GG | 1.494 (0.269 to 8.295) | 0.646 | 0.148 | 52.3 | n.a | ||||
AA vs AG+GG | 1.241 (0.127 to 12.115) | 0.852 | 0.050 | 74.0 | n.a | ||||
AA+AG vs GG | 1.932 (0.169 to 22.029) | 0.596 | 0.042 | 75.9 | n.a | ||||
VEGFR 2 | Rs 2071559 A>G | Caucasian | A vs G | 1.018 (0.885 to 1.171) | 0.805 | 0.750 | 0.0 | 0.475 | |
AA vs GG | 1.025 (0.775 to 1.355) | 0.862 | 0.865 | 0.0 | 0.475 | ||||
AG vs GG | 0.998 (0.790 to 1.261) | 0.985 | 0.139 | 45.4 | 0.699 | ||||
AA vs AG+GG | 1.040 (0.821 to 1.318) | 0.744 | 0.941 | 0.0 | 0.319 | ||||
AA+AG vs GG | 1.010 (0.810 to 1.258) | 0.933 | 0.239 | 28.9 | 0.156 |
Bold text highlights positive results.
*If the p value for Q-statistic was >0.10 or the I2 value was ≥50%, a REM was used, otherwise a FEM was adopted.
FEM, fixed-effects model; n.a, not available; nAMD, neovascular age-related macular degeneration; REM, random-effects model; VEGF-A, vascular endothelial growth factor A; VEGFR, vascular endothelial growth factor receptor.